|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
|
|---|---|---|---|
| Assets: | |||
| Current assets | |||
| Cash | |||
| Other receivable | |||
| Prepaid expenses | |||
| Prepaid insurance | |||
| Total current assets | |||
| Long-term prepaid insurance | |||
| Cash and investments held in Trust Account | |||
| Total Assets | |||
| Liabilities, Class A Ordinary Shares Subject to Possible Redemption and Shareholders' Deficit: | |||
| Current liabilities | |||
| Accrued expenses | |||
| Accrued offering costs | |||
| Total current liabilities | |||
| Deferred legal fees | |||
| Advisory fee payable | |||
| Deferred underwriting fee payable | |||
| Derivative liabilities - warrants | |||
| Total Liabilities | |||
| Class A ordinary shares subject to possible redemption, 27,600,000 shares at a redemption value of $10.21 and $10.03 per share as of June 30, 2026 and December 31, 2025, respectively | |||
| Shareholders' Deficit | |||
| Ordinary shares | |||
| Class A ordinary shares not subject to possible redemption | |||
| Class B ordinary shares | |||
| Accumulated deficit | |||
| Total Shareholders' Deficit | |||
| Total Liabilities, Class A Ordinary Shares Subject to Possible Redemption and Shareholders' Deficit |
Loading...
